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Abstract 
Two bottlenecks that have impeded the genetic analysis of complex traits in inbred 
strain crosses and populations derived from them, are the lack of gene level mapping 
resolution and the need for population specific genotyping arrays and haplotype 
reference panels. To address these problems we mapped multiple complex traits at high 
resolution in a highly recombinant commercially-available outbred mouse population, 
using imputed genotypes from 0.15x whole genome sequencing. By simultaneously 
imputing the ancestral haplotype space comprising 5,766,828 single nucleotide 
polymorphisms and the genomes of the mapping population at 359,559 tagging variants, 
we mapped 255 quantitative trait loci representing 156 unique regions in 1,887 mice for 
92 phenotypes. Linkage disequilibrium decays fast enough to provide gene-level 
mapping resolution at about a fifth of loci. Our results implicate Unc13c and Pgc1-alpha 
at loci affecting the quality of sleep, Adarb2 for home cage activity, Rtkn2 for intensity of 
reaction to startle, Bmp2 for wound healing, Il15 and Id2 for several T-cell measures and 
Prkca for bone mineral content. Six diverse phenotypes map over the Met gene: muscle 
weight, startle response, serum albumin, calcium, protein and cholesterol levels, 
suggesting this is an important pleiotropic locus.  These findings have implications for 
diverse areas of mammalian biology and demonstrate how GWAS can be extended via 
low-coverage sequencing to species with large highly recombinant outbred populations. 
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Introduction 
Genome-wide association studies (GWAS) have delivered new insights into the biology 
and genetic architecture of complex traits but so far they have found application 
primarily in human genetics1,2 and in plant species where naturally-occurring inbred 
lines exist 3,4 . Two obstacles stand in the way of their routine application in other 
species: access to a mapping population able to deliver gene-level mapping resolution, 
and the deployment of a genotyping technology able to capture at least the majority of 
those sequence variants that contribute to phenotypic variation, in the absence of 
haplotype reference panels of the kind routinely employed in human populations to 
impute sequence variants.    
In this study we exploit the properties of commercially available outbred mice for 
GWAS in the Crl:CFW(SW)-US_P08 stock. Compared to other mouse mapping 
populations, commercial outbred mice are maintained at relatively large effective 
population sizes and are descended from a relatively small number of founders, with 
mean minor allele frequencies and linkage disequilibrium (LD) resembling to those 
found in genetically isolated human populations 5. While LD extends over a larger range 
than in general human populations, such populations can still deliver gene level 
resolution 5. Furthermore, compared to a human GWAS, comparatively fewer markers 
are needed to tag the genome, thus requiring a lower significance threshold and smaller 
sample sizes than are usual for a human GWAS.  
GWAS methodology typically uses arrays to genotype known Single Nucleotide 
Polymorphisms (SNPs) and hence represent each individual’s genome as a haplotype 
mosaic of a reference panel of more densely typed or sequenced individuals (such as the 
1000 Genomes project 6), to impute genotypes at the majority of segregating sites in a 
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population 7. However, in common with other populations that have not previously been 
subject to GWAS, commercial outbred mice lack accurate catalogs of sequence variants, 
allele frequencies and haplotypes, thus excluding the application of standard GWAS 
approaches.  
We show here how low coverage sequencing overcomes these limitations. We 
apply a method that models each chromosome as a mosaic of unknown ancestral 
haplotypes that are jointly estimated as part of the analysis, exploiting phase information 
in sequence reads to optimize haplotype reconstruction. Using this approach we map the 
genetic basis of multiple phenotypes in almost 2000 mice, in some cases at near single-
gene resolution, thereby providing insights into the biology of a number of bio-medically 
important traits.  
 
Results 
Phenotypes 
For this experiment we chose the Crl:CFW(SW)-US_P08 outbred stock (CFW) from 
Charles River, Portage, USA 5 and subjected 2,049 adult mice to a four-week phenotyping 
pipeline (see Methods and Supplementary Figure 1). The phenotype battery is notable 
for both the depth of information provided (anatomical, biochemical, immunological, 
physiological and behavioral measures) as well as the assessment of phenotypes rarely 
mapped in mice. The latter include assessments of sleep and cardiac electrical function 
(electrocardiography). We provide measures for 200 phenotypes from 18 assays 
(Methods), for each of which data are available on a mean of 1,578 animals (range 905 - 
1,968). We assign each measure to one of the following three heuristic categories: 
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behavior, physiological or tissue; physiological measures include those taken when the 
mice were alive such as body weight and cardiac function, while the tissue measures 
comprise those obtained after dissection such as blood clinical chemistry and 
neurogenesis. Supplementary Table 1 lists the phenotypes reported here, the category to 
which they belong, the means and standard deviations on all animals and also separately 
for each sex. For 63% of the measures males and females are significantly different at 
P<0.05. We tested the effect of all potential covariates on the variance of each measure in 
order to regress them for the genetic analysis. The strongest effect comes from the batch, 
affecting 190 measures with a mean effect of 15%. This is unsurprising as batch is 
confounded with many environmental factors including shipment, time of year or 
experimental day. 
 
Genotypes 
In order to capture all common variants in the CFW mice, we employed a two-stage 
genotyping strategy using low coverage sequencing that makes use of, but does not 
require, prior knowledge of segregating sites. We first generated a list of candidate 
variant sites using GATK 8 and then imputed genotype probabilities at these sites.  
We obtained a mean coverage of 0.15X sequence coverage per animal for 2,073 
mice (range 0.06X to 0.51X). We identified 7,073,398 single-nucleotide polymorphisms 
(SNPs) in the ~370X pile-up of all sequence data that segregated in our sample and were 
either polymorphic in laboratory strains sequenced in the mouse genomes project 
(MGP) (3), or passed GATK’s variant quality score recalibration (VQSR) (Methods). We 
then imputed genotype dosages at these sites using our reference-panel free method, 
STITCH (Methods, and described in Davies et al 2016). After stringent post-imputation 
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quality control we retained 5,766,828 high-quality imputed SNPs for subsequent 
analysis. Accuracy at these sites is very high: the mean SNP-wise correlation (r2) against 
sites polymorphic on a genotyping microarray9 using 44 samples was 0.974 before QC 
and 0.981 after QC. We annotated the high-quality imputed SNPs using the mouse 
reference mm10 assembly and identified 11,931 SNP positions in protein coding 
sequence that lead to amino acid changes in 3,938 individual genes (non-synonymous 
substitutions) and 25,669 that do not (synonymous substitutions). Supplementary Table 
2 lists the variants per chromosomes and Supplementary Table 3 lists the number of 
variants obtained at each stage of the variant calling and imputation process. 
Genetic architecture  
Inspection of the genetic variation segregating in CFW mice revealed several notable 
characteristics. The total of 5.7 million variants in the CFW mice is about 1/3 fewer than 
the number segregating in crosses derived from classical laboratory inbred strains 
(heterogeneous stocks10, 11, Hybrid Mouse Diversity Panel, HMDP 12) but far less than the 
45 million segregating in the recently created Collaborative Cross (CC) and Diversity 
Outbred (DO) populations using wild-derived strains from different subspecies of mice 
11. 
The distribution of variants across the genome was highly non-uniform (Figure 
1A). Chromosome 16 has only 20% of the variants found on chromosome 15, despite 
being almost the same size (Supplementary Table 2). This likely reflects an extreme 
bottleneck in the founding of the CFW, a view supported by the fact that only four 
ancestral haplotypes were required for the imputation procedure to work effectively. On 
chromosome 19, on average, at each SNP 87.1% of samples are represented by only two 
haplotypes.  
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Rates of heterozygosity are low (Figure 1B) with 22% of the genome close to 
fixation (Figures 1A and 1C). Of the 5.7M imputed variants, 97.6% were found in 36 
sequenced inbred strains in the Sanger Mouse Genomes database Release 1505. The 
FVB/NJ strain alone contributes 38% of non-reference CFW alleles (Supplementary 
Table 4) and in combination with the progenitors of the mouse HS45 account for 76%. 
Wild-derived strains (LEWES/EiJ, ZALENDE/EiJ, WSB/EiJ, CAST/EiJ, MOLF/EiJ, 
PWK/PhJ, SPRET/EiJ) only account for about 5% of alternative alleles absent from other 
sequenced strains. 11,13. Both novel and known variants have very similar minor allele 
frequency distributions across the genome (Figures 1C and 1D). Average minor allele 
frequency (MAF) was 0.19, with 18.4% of variants having MAF <0.05. Figure 1E shows 
the decay of linkage disequilibrium with increasing distance (providing an indication of 
the expected mapping resolution obtainable with the CFW mice). Average pairwise r2 
falls to 0.28 at 1Mbp, 0.16 at 2 Mbp, and 0.10 at 3 Mbp. We identified a subset of 359,559 
SNPs, that tag all other SNPs with MAF >0.1% at LD r2>0.98. This subset was used for 
subsequent analyses except where stated otherwise. 
To investigate population structure and unequal relatedness between the 2073 
mice, we estimated identity by descent (IBD) from allele sharing between tagging SNPs 
(Methods); Supplementary Figure 2 plots the proportion of genome with IBD = 1 against 
IBD = 0. For GWAS, we removed 135 animals with higher relatedness than second-
degree relatives, and 4 outliers identified from principal component analysis (PCA) on a 
genetic relatedness matrix (GRM, Methods). The population structure of the remaining 
1934 animals was further assessed by performing another PCA on a GRM from only 
these mice; Supplementary Figure 3 plots the relationship between the first 5 principal 
components and shows no evidence of extensive structure.   
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Genome-wide association 
Genotypes and phenotypes were available for 1887 mice. We performed GWAS by 
testing association between the 359,559 tagging SNPs and all phenotypes. We first 
transformed each phenotype by regression on relevant covariates (see Methods) and 
quantile-normalised the residuals. We used a genetic relationship matrix (GRM) in a 
mixed linear model to control for population structure and genetic relationship. To test 
for association with SNPs on a given chromosome, we used a GRM based on those 
tagging SNPS on the other chromosomes 14,15 to increase power 16. We calculated a 
genome-wide false discovery rate (FDR) separately for each phenotype, using 
permutations of the mixed model-transformed phenotypes to determine empirical trait-
specific genome-wide significance thresholds (Methods).  
At a 5% FDR, we identified 255 QTLs in 92 out of 200 phenotypes (46%), as 
shown in Supplementary Table 5. Quantile-quantile plots for a representative selection 
of phenotypes are given in Supplementary Figure 4. It should be noted that due to the 
large number of SNPs used (in this case not pruned for LD) and the fact that LD extends 
over longer distances than exist in human populations, deviation from the expected 
values extends over a larger range of P-values than is commonly seen in quantile-
quantile plots generated for human association studies.); plots of all QTLs are available 
at http://outbredmice.org).  Statistical power is expected to increase with MAF, and in 
our QTLs the MAF of significantly associated SNPs (range 1.7-50%, median 31%) was 
higher than expected (compared to all 5.7M SNPs) (Mann Whitney U test, P = 1.95e-28): 
133 QTLs (52%) have a MAF>30% and only 11 (4%) below 5% (Figure 2a). Among the 
5.7M imputed SNPs, 25% have MAF>30% and 18% MAF<5% (Figure 1c). 
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 To aid gene identification, we estimated the 95% confidence intervals (CI) of 
every QTL using a method based on the LOD-drop concept17. To do so, around each QTL 
we simulated causal SNPs that matched the QTL’s observed effect size. A local scan of the 
region using the same mixed model but using a simulated phenotype was performed, 
and the location and LogP of the top SNP recorded. From 1,000 simulations, we derive a 
distribution of the drop (∆) in LogP between the most highly associated SNP and the 
causal SNP (∆ is zero when the top and causal SNPs coincide).  Since the width of the 
interval containing ∆ is well-calibrated with respect to true confidence intervals 17, the 
fraction of simulations 𝑓(∆) within ∆ can be used to determine confidence intervals for 
the original phenotype data 17. The 95% CIs ranged from 0.01-7.33Mb with a mean at 
1.50Mb; 43% of QTLs being less than 1Mb in size. On average each QTL covered 19 
protein coding genes (0-205) with a median of 9 genes. Figure 2b shows the distribution 
of the number of genes at a QTL. Mapping results can be visualised at 
http://mus.well.ox.ac.uk/gscandb/ (GScanViewer) 18 and at http://outbredmice.org. 
 
Heritability and variance attributable to QTLs  
SNP-based heritability estimates, h2, based on a GRM computed from the tagging SNPs, 
were greater than 0 (at P<0.05) for 152 of 200 phenotypes, with a mean value of 26.3%, 
(range 9.1-71.1%), as reported in Supplementary Table 1. To assess how much of the 
heritability can be explained by detected QTLs (FDR<5%), we first estimated the effect 
size of each QTL by performing analysis of variance (ANOVA) at the most significantly 
associated SNP then summed the variance explained by all QTLs associated with every 
phenotype. On average, 21.1% of the heritability estimated for each trait with significant 
h2 estimates can be explained in this way (Figure 2c). This indicates that missing 
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heritability affects the CFW population, although to a lesser degree than most human 
GWAS. 
Traits with higher heritabilities yielded more QTLs than traits with lower 
heritabilities: the mean heritability of those traits for which at least one QTL was 
identified was 30.6%, compared to a mean heritability of 20.6% for those traits for 
which no QTLs were detected, a highly significant difference (t-test P-value = 8.9x10-8). 
Mean heritabilities differed between the three categories of phenotypes: 14.5% for 
behavior, 18.2% for physiological and 24.2% for tissue phenotypes. We also noted the 
same pattern in the median locus effect size of the three categories: 1.37% for 
behavioural QTLs, 1.5% for physiological and 2.8% for tissue QTLs (Figure 2c). 
 
Distribution of QTLs reflects genetic diversity along the genome 
Many of the loci detected overlap, and are associated with, closely related phenotypic 
measures. Examples include the 2 QTLs for HDL and total cholesterol mapping over the 
Apoa2 gene on chromosome 1 19, or the 8 different bone mineral content measures 
mapping over Slc4a2 on chromosome 5 20. To avoid redundancy in our analysis we 
considered that if two overlapping QTLs (where the top SNP of the first QTL lies inside 
the 95% CI of the second QTL) were associated with measures of the same biological 
function they were representing a unique locus. Using this approach we identified a 
reduced set of 156 unique loci, each associated with 1 to 12 measures. We report these 
156 unique QTLs in Supplementary Table 6 with all the measures associated with each 
locus. A “porcupine” plot on Figure 3 shows the superimposed Manhattan plots of all the 
measures where a least one QTL was detected and highlights the 156 unique loci. Some 
regions of the genome are devoid of any QTLs, reflecting the uneven genomic 
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distribution of sequence variants, a prime example being the lack of any QTL detected on 
chromosome 16 (Figure 1A). Figure 3 also highlights the presence of clusters of QTLs, 
notably on chromosomes 6, 11, 17 and X. The chromosome 17 locus overlaps the major 
histocompatibility complex (MHC), a naturally highly polymorphic region in wild 
populations that remains highly variable in the CFW mice. 
 
High-resolution QTLs confirm known genetic associations and identify novel candidate 
genes 
We focused on those QTLs containing small numbers of genes, since these loci provide a 
starting point for functional investigation of the relevant phenotypes. Of the 156 unique 
loci identified in this study, 56 contain three or fewer genes (36%) and 25 contain a 
single gene in the 95% confidence interval (6 QTLs do not overlap any gene).  
Table 1 lists the 25 QTLs containing a single gene. The table categorizes QTLs into 
three classes, according to prior evidence supporting the candidacy of the gene at the 
locus. (i) Phenotypes of knockouts support candidacy of three genes: Met, Fli1, and Grm7. 
The locus on chromosome 6 containing the Met gene contributes to all five muscles 
weight measures (Figure 4a). Met encodes a hepatocyte growth factor receptor and has a 
known function in embryonic development 21,22 and regeneration23 of adult limb skeletal 
muscle. Fli1 modulates B cells development 24 and mice lacking Grm7 are more active 
when placed in a novel environment 25  (ii) The genes at six loci are strongly 
corroborated by prior published evidence. These include the bone morphogenetic 
protein Bmp2 at a locus for wound healing 26; PGC-1α, at a locus for sleep fragmentation, 
is involved in regulating inhibitory neurotransmission in the cerebral cortex associated 
with cortical hyperexcitability 27; a protein kinase (PKCα) that promotes osteoblastic cell 
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proliferation, at a locus for bone mineral content 28,29; the pre B cell leukemia homeobox 
1 (Pbx1) at a locus influencing NK cells population 30 and finally an Interleukin (Il15, Fig 
4d) 31 and the transcription factor Id2 32 at two independent loci affecting several T-cell 
measures.  (iii) The remaining 16 QTLs contain single genes not previously associated 
with the trait, including 5 that concern behaviour. Notably, our mapping results 
implicate Unc13c in the quality of sleep (duration of long bouts of sleep, Fig 4b). UNC13C 
is involved in synaptic transmission 33, but has never previously been associated with 
sleep. However, there is evidence for the differential expression of the human ortholog in 
individuals with poor sleep quality34. Basal home cage activity is associated with Adarb2, 
a brain-specific adenosine deaminase acting on RNA 35,36. Rtkn2, a member of the 
rhotekin family predominantly expressed in lymphoid cells 37, influences intensity of 
reaction to startle (Fig 4d). CNVs for the human orthologue of Rtkn2 have been 
implicated in attention-deficit and hyperactivity disorder 38. Similarly, the QTL for 
hypoxic ventilatory depression maps to the Hcn1 gene encoding a hyperpolarization-
activated cyclic nucleotide-gated cation channel.  
The low-coverage population-based sequencing approach used in this study 
provides a near complete catalogue of the SNPs segregating in our population, most 
importantly identifying SNPs that would have been ignored using microarrays for 
genotyping. We could also test associations at candidate variants responsible for the 
effect. The Met gene on chromosome 6 is associated with muscle phenotypes and our 
sequence data revealed two missense variants: I851M and R968C. The first variant is 
common amongst mouse inbred strains and is not known to alter gene function. The 
second variant, confirmed by Sanger sequencing, is specific to the SWR/J strain 39. The 
human homolog (R988C) has been identified in two small cell lung cancer cell-lines and 
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increases constitutive tyrosine phosphorylation activity in vitro 40. The R968C missense 
variant is highly associated with the five muscle weight phenotypes but the direction of 
the effect of the alternative allele is positive in extensor digitorum longus (EDL) and 
gastrocnemius and negative in the others. This difference reflects differences in the 
muscle fiber composition (soleus is dominated by type 1 and 2A fibers, EDL is enriched 
in 2X and 2B fibers 41) suggesting that R968C affects these fibers differently or shifts the 
composition in all muscles. 
 
Discussion 
Genome-wide association mapping for complex traits has been used extensively in 
human populations but less commonly in outbred populations of other organisms. We 
have shown here that mapping using commercially available outbred mice can identify 
individual genes involved in complex traits, some of which cannot easily be assayed in 
human subjects. Our results raise issues about the nature of mouse resources for 
mapping complex traits, and about the biological insights that can thereby be attained.  
Several resources have been developed to provide GWAS tools to rodent genetics. 
These resources fall into two broad categories: (i) genetic reference populations, 
consisting of pre-existing inbred strains (Hybrid Mouse Diversity Panel, HMDP 12) or 
recombinant inbred strains (BxD42 and Collaborative Cross43), (ii) populations 
descended after multiple generations of pseudo-random breeding from inbred strains 
(diversity outcross (DO) mice 44 and heterogeneous stocks (HS)45).  Each resource differs 
in its utility for GWAS, and no single population is ideal 1. 
 Commercially available outbred mice are an alternative resource with a number 
of advantages, and the CFW stock has already been used to map skull shape QTLs 46. 
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Compared to HMDP and HS animals, there was minimal evidence for population 
structure, and standard GWAS methods developed for human populations can be 
applied. LD decays fast enough to provide gene-level mapping resolution at about a fifth 
of loci, and although the resolution is still lower than in human populations, it is better 
than other mouse resources. The size of QTLs varied considerably, with the largest ones 
extending over several megabases, but half contained less than 10 genes, providing a 
relatively small list to investigate the biology at these sites.   
Compared to other rodent mapping resources, our results also indicate that the 
CFW population delivers fewer loci for fewer phenotypes. We mapped loci for 92 out of 
200 traits included in our phenotyping pipeline, yielding a mean number of 1.3 QTLs per 
trait, in 1,887 mice. One possible explanation for the low yield of QTLs is that the amount 
of genetic variation present in the CFW stock is relatively limited. Indeed, almost a 
quarter of the CFW genome is virtually devoid of variants (including almost all of 
chromosome 16). For comparison, the 5.7M variants in the CFW is less than the 7.2M 
segregating in the rat heterogeneous stock 10. However, a more important determinant 
for QTL detection in the CFW is likely to be allele frequencies (𝑝), which are on average 
lower in the CFW than in the HS. Since the variance explained by a QTL is proportional to 
𝑝(1 − 𝑝), effect sizes, and hence power, are systematically smaller in the CFW.  Indeed, 
the median effect size is 1.6%, which, while dwarfing the effects found to underlie human 
quantitative traits, is still less than half that found in the rat HS (median estimate 5%) 10. 
Supplementary Table 7 summarises the expected power to detect QTLs in the CFW 
population.   
The inclusion of a large number of behavioural measures in our pipeline also 
contributed to the relatively low QTL detection rate. Almost a third of the traits  
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(63/200) were collected from behavioral tests, yet the QTLs mapped with these 
measures accounted for less than 14% of the total.  These phenotypes typically had 
lower heritabilities, with fully one quarter (16) having no significant genetic 
contribution.  It should be noted that these non-significant estimates (as well as those for 
non-behavioural phenotypes) do not necessarily mean the traits are not heritable: as 
shown in Supplementary Table 1, the standard errors on these estimates are large, so 
that no heritability less than 10% can be reliably estimated.  Those loci we did detect had 
lower effect sizes (mean for behavioural QTLs was 1.37, compared to 1.5 for 
physiological and 2.8 for tissue QTLs). 
The heritability of the behavioural measures might also have been affected by the 
fact that mice were repeatedly tested over a 4 weeks period. Most behaviors are 
sensitive to repeated handling and repeated exposure to different types of novel stimuli, 
as will happen during the extensive phenotypic battery deployed here. Habituation to 
these exposures makes it harder to detect alleles that affect baseline differences in 
behavior, especially anxiety-like behaviors for which three different assays were 
conducted over a relatively short time frame. A more focused assessment of a specific 
behavioral phenotype under tightly controlled environmental conditions could have 
yielded higher heritabilities for some traits. 
These observations lead to two conclusions. First, finding more QTLs in the CFW 
will require thousands of mice. Supplementary Table 6 gives the power to detect QTLs in 
the CFW population as a function of effect size and sample size. For a typical QTL 
corresponding to the median effect size (1.6%) and sample size (1,732) in the current 
study, power is about 80% at a genomewide significance level of 10%. Power falls off for 
smaller effects sizes. Thus a 0.5% QTL is detectable at only 6.6% power with 1,732 
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animals; increasing the sample size to 4,000 increases the power to 51%, and with 6,000 
it is 85%. However, “winner’s curse” means that the true effects are likely to be lower 
than reported here, and given that our QTLs explain only 20% of the heritability it is 
reasonable to assume that the majority of loci will have effect sizes less than 1%. Second, 
additional loci can be found using different stocks. Not all commercial outbred mice 
populations are the same, as we previously documented in a survey of 66 stocks in which 
mean heterozygosity varied from 0.5% to 45% and mean minor allele frequencies from 
0.03% to 0.5%5. The use of complementary populations will make additional alleles open 
to discovery.  
Our study is the first to use extremely low coverage sequence to generate 
accurate genotypes without a reference panel. This strategy is generally applicable to 
any population, and any species, for which there is no information about segregating 
variation or haplotypes. It is competitive with arrays in terms of cost, although the 
optimal choice of strategy will depend on the reagents available for the population in 
question. An advantage of sequencing over array-based genotyping is that it does not 
require prior information about which variants are segregating in a population; nor does 
it require a pre-existing catalogue of variants or prior knowledge of the likely founders 
of the population.  
One unexpected finding was that, only 25,000 SNPs in the standard megaMUGA 
mouse genotyping array are polymorphic in the CFW mice; many of the QTLs we 
mapped would likely have been overlooked by genotyping with this array.  The CFW 
mice appear to be descended from four ancestral haplotypes, indicating this population 
was likely bottle-necked to two founding individuals. Our population is effectively bi-
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allelic at most loci, and there was little to be gained by considering haplotype-based tests 
of association (data not shown). 
We have shown here how commercially available outbred mice can deliver novel 
biological insights. We found single genes at 16 loci where no prior evidence existed for 
their involvement (Table 1). Importantly, the loci include those from phenotypes that 
could not easily be assayed in human subjects, such as response to hypoxia and the sleep 
phenotypes. More than 50 QTLs contain documented candidate genes (Supplementary 
Table 5): Slc4a2, which leads to osteopetrosis when disrupted in mice 20, is present at a 
QTL affecting bone mineral content; Apoa2 and Scarb1, both known to affect blood lipid 
homeostasis 19,47 are detected at two distinct QTLs for cholesterol levels; Gdnf, a gene 
required for the neuronal colonization of the pancreas, at a locus for pancreatic amylase 
48. These examples demonstrate that the narrow QTLs detected in the commercially 
available outbred mice can lead to the identification of the genes affecting the measured 
traits, emphasizing the potential of our results as a resource to identify new genes in 
those QTLs without documented candidates. 
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Methods 
 
Study animals and phenotyping 
A total of 2117 outbred mice (Crl:CFW(SW)-US_P08, 1065 males and 1052 females) 
were purchased from Charles River, Portage, USA at 4-7 weeks of age over a period of 2 
years. Animals were selected from the breeding colony as to avoid siblings and half-
siblings. Monthly shipments of approximately 130 mice were delivered, maintained and 
tested at the MRC Harwell in Harwell, Oxfordshire, UK following local regulations. Mice 
of the same age within each shipment were treated as a batch (approximately 30 
animals, range 7 to 36, half males and half females, the total number of batch for the 
entire study is 69) and each animal randomly assigned a testing order. Mice were housed 
in IVC cages (3 per cage) on an ad lib diet for the duration of the study. At 16 weeks of 
age 2049 mice started a 4-weeks phenotyping pipeline in which we collected behavioral 
and physiological data (Suppl. Fig. 1). Mice within a batch performed each test during the 
same day following the assigned testing order. The sequencing of the animals was 
performed after completion of the study so experimenters were blind to the genotype of 
the mice during testing. Power calculations to estimate the sample size for the mapping 
experiment assumed effect sizes were similar to those identified in a previous analysis of 
outbred stocks 5. Every effort was made to minimize suffering by considerate housing 
and husbandry. All phenotyping procedures were examined for potential refinements. 
All animal work was carried out in accordance with UK Home Office regulations. The 
project was reviewed by the ethics committee at MRC-Harwell: Animal Welfare and 
Ethical Review Board, approval license PPL 30/2653. 
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Behavior 
Anxiety was modeled by 3 tests: Five minutes activity in a bright lit round arena (Open 
Field Test), Elevated Plus Maze and latency to eat a novel food after 10 hours food 
restriction (Neophagia). We also measured home cage activity over a 30 minutes period 
using photoactivity system from San Diego Instruments (San Diego, CA). Protocols for 
these tests have been described in 49. Pre-pulse inhibition of startle (Startle PPI) was 
measured and analyzed as previously described, using 3 different pulse and 3 different 
prepulse intensities 50,51. Fear conditioning was performed following the protocol in 52, 
keeping the order of context and cue testing sessions identical for all mice. On the first 
day of the test mice were subjected to a 13 minutes training session during which they 
were placed in a Perspex enclosure with a metal grid floor and received 2 electric foot 
shocks (0.3mA, 0.5sec) preceded by a 30 seconds tone.  In the morning of the second day 
of the test the mice were placed in the same enclosure for 5 minutes and fear associated 
with the context was measured by the amount of freezing. In the afternoon the animals 
were placed in a different enclosure for 5 minutes where they were subjected to two 30 
seconds tones without any paired electric shock. The fear associated to the cue was 
assessed by measuring the freezing behaviour during tones. Freezing behaviour during 
all sessions of the test was scored using a VideoTrack automated system (Viewpoint, 
Champagne Au Mont D'Or, France). Because the distribution of the measures varied 
significantly between the 4 enclosures in which the mice where tested for fear 
conditioning, we quantile normalised the data per enclosure before performing further 
analysis. Depressive-like behavior of mice was assessed with the forced swim test 53. 
Animals were placed for 6 minutes in a 30cm diameter plastic cylinder filed with water 
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at 25°C. Immobility of the mice during the last 4 minutes was scored using VideoTrack 
FST automated system (Viewpoint, Champagne Au Mont D'Or, France). 
Ventilatory responses to acute hypoxia 
Ventilatory responses to acute hypoxia were measured using whole body 
plethysmography. Awake unrestrained mice were placed in individual plethysmographs 
(550 ml volume, Model PLY3211, Buxco, Wilmington, NC USA) to which premixed gases 
were delivered at a rate of 2 L min-1. After a brief (5-min) acclimatisation period, mice 
were exposed to 15 min of 21% O2, balance N2 (pre-normoxia), followed by 5 min of 
10% O2, balance N2 (hypoxia), followed by a final 5-min period of 21% O2 (post-
normoxia). Tidal volume (TV) and respiratory frequency (f) were measured 
continuously, and used to calculate minute ventilation (MV). For each of these three 
parameters, the following indices of the respiratory phenotype were derived: i) Baseline 
(mean value for MV, TV or f during the final 3 min of pre-normoxia); ii) Acute Hypoxic 
Response (AHR, difference between the mean value during first 30 sec of hypoxia and 
the Baseline); iii) Hypoxic Ventilatory Decline (HVD, difference between mean value 
during the first 30 sec of hypoxia and mean value during final 2 min of hypoxia); iv) 
Undershoot (difference between mean value during the first 30 sec of post-normoxia and 
the Baseline); v) Off-Response (difference between mean value during first 30 sec of 
post-normoxia and mean value during final 2 min of hypoxia); vi) Sustained Hypoxia 
Response (SHR, difference between Off-Response and Undershoot); and vii) Normoxic 
Recovery (NR, difference between value during first 30 sec of post-normoxia and final 2 
min of post-normoxia). 
Electrocardiography 
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For surface electrocardiography (ECG), mice were anesthetized using isoflurane 
inhalation (induction: 4.0 volume % in oxygen; maintenance: 1.5-2.5 volume %). Surface 
ECGs were recorded from subcutaneous 23-gauge needle electrodes attached to each 
limb using the Powerlab acquisition system (ADInstruments). ECG traces were signal 
averaged and analysed for heart rate (RR interval), PRmain (interval between start P 
wave and start QRS complex), PRpeak (interval between start P wave and R peak), 
QRSmain (interval between start of QRS complex and S peak), QRSpeak (interval 
between R peak and S peak), QTmain (interval between start of QRS complex and end of 
T wave), and QTpeak (interval between R peak and end of T wave) using the 
LabChart7Pro software (ADInstruments). QTmain and QTpeak intervals were corrected 
for heart rate using the formula: QTc=QT/(RR/100)1/2 (RR in ms). 
Sleep 
At the end of the phenotyping pipeline mice were moved to individual cages to assess 
their baseline sleeping behaviour using a non-invasive EEG-validated piezo-electric sleep 
recording system 54 (MouseRec system by Signal Solutions, LLC, Lexington, KY, USA). 
Sleep was recorded for 72 hours but only the last 48 hours were used for analysis thus 
allowing one day of habituation. Light-dark cycle (12h:12h light:dark) and ambient 
temperature (21°C) during the recordings were the same as in the colony rooms. In each 
of the 1607 mice for which good quality signals could be obtained, 19 sleep phenotypes 
were quantified concerning the amount of sleep, its distribution over the 24h day, and 
the fine structure of sleep (e.g. sleep bout duration and sleep fragmentation). All values 
are reported per 24h and represent the average over the last two 24h recording periods 
starting at light onset.  
Body weight 
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We measured body weight at 17, 18, 19 and 20 weeks of age. The last measure was 
collected immediately before sacrifice after overnight fast. We calculated Body Mass 
Index (BMI) by dividing the body weight at 20 weeks by the square of the body length, 
collected at the same time. We also calculated a “pseudo BMI” dividing the body weight 
at 20 weeks by the square of the length of the tibia. 
At 20 weeks of age mice were sacrificed between 8am and 12pm after overnight food 
restriction and tissues harvested for further measures. We measured body and tail 
length during the procedure. 
Haematology 
Whole blood samples for haematology were collected by cardiac puncture into 200µl 
EDTA coated paediatric tubes. Samples were placed on a rotary mixer for 30 minutes 
before full blood count and differential analyses were performed on board a Siemens 
Advia 2120 haematology analyser.  
Clinical Chemistry 
Blood samples were collected by cardiac puncture into 1ml lithium heparin-coated 
paediatric tubes. Samples were mixed by gentle inversion and centrifuged within 2 hours 
of collection at 5000 X g, for 10 minutes in a refrigerated centrifuge set at 8°C. 200µl of 
plasma was collected from each sample and analysed on board a Beckman Coulter 
AU680 clinical chemistry analyser using reagents and settings as recommended by the 
manufacturer for the following profile of 20 tests: sodium, potassium, chloride, urea, 
creatinine, total calcium, inorganic phosphorous, alkaline phosphatase (ALP), alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), lactate hedydrogenase 
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(LDH), total protein, albumin, total cholesterol, HDL cholesterol, LDL cholesterol, 
glucose, triglycerides, glycerol, free fatty acids, total bilirubin, iron and alpha amylase.  
Platelet serotonin 
A small aliquot of whole blood was immediately snap frozen after collection by cardiac 
puncture into a lithium heparin-coated tube. At the time of measure 10µl of this whole 
blood aliquot was thawed and used for serotonin quantification. Serotonin was extracted 
by adding 390 µl of 10-3 M HCl containing sodium metabisulfite, EDTA and ascorbic acid. 
After 30 sec shaking, samples were centrifuged at 20000g for 20 min at 5°C. The 
supernatants were collected and filtered through a 10 kDa membrane (Nanosep, Pall) by 
centrifugation at 7000g. Then, a 20 µl aliquot was analysed for serotonin by fluorometric 
detection 55. 
Micronucleus 
We measured the formation of micronuclei, markers of genomic stability, in erythrocytes 
by flow cytometry 56. 
Neurogenesis 
Following sacrifice the brain was weighted and then split in two halves by sagittal 
section and the left hemisphere fixed overnight in 4% paraformaldehyde followed by 
dehydration in 30% sucrose solution for 3-5 days. Sections (40 μm) were prepared on a 
freezing microtome and stored in antifreeze solution at −20°C. We measured 
hippocampal neurogenesis by Ki67 and DCX staining 57, counting labelled cells on every 
sixteenth (DCX) or eighth (Ki67) section through the entire rostrocaudal extent of the 
granule cell layer.  
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Wound healing 
We measured healing of hole punctures made to the animal’s ears following the 
approach described in 58. A 2-mm diameter hole was made in the center of each ear 
when the mice started the phenotyping pipeline (16 weeks old) and following sacrifice 5 
weeks later ears were fixed and stored in 4% paraformaldehyde. Both ears were then 
flattened between 2 coverslips, scanned at 600dpi and the image analysed with the 
ImageJ software to measure the area of the hole still open. We excluded ears when the 
hole merged with the edge of the ear and only analysed mice when both ear measures 
were available. 
Adrenal weight 
Following sacrifice adrenals were removed together with the kidneys, fixed and stored in 
4% paraformaldehyde. Adrenals were dissected from the kidneys at a later day and their 
weight measured. Data was analysed only when weight from both adrenals was 
available. 
Immunology 
Following sacrifice, mouse spleens were stored in PBS on ice prior to processing. 
Splenocytes were extracted by mashing the spleen through a 45μm filter using the 
plunger end of a syringe. The cells were then washed extensively with PBS and re-
filtered prior to staining. Erythrocyte contamination in the splenocyte sample was 
minimal. Splenocytes were stained with fixable near-IR dead cell stain (Life 
Technologies), CD3e PE Cy7, CD45 V450, CD44 FITC, CD4 V500 (all BD Bioscience), 
CD49b APC, CD19 PE, CD8a PerCP Cy5.5 (all eBioscience) for 25 minutes in the dark at 
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4°C before being fixed in 2% formaldehyde solution. Data were collected using a 3-laser 
LSRII or MACSQuant flow cytometer and analysed on Flowjo v8.4 (Treestar, OR, USA).  
Muscle weight and tibia length 
Following sacrifice, one hindlimb was removed and transferred to a -70 °C freezer. On 
the day of dissection, the leg was defrosted and two dorsiflexors (tibialis anterior (TA), 
and extensor digitorum longus (EDL)), and three plantar flexors (gastrocnemius 
(“gastroc”), plantaris and soleus) were dissected under a microscope.  Each muscle was 
weighed to a precision of 0.1 mg on a balance (Pioneer, Ohaus).  A panel of muscles was 
examined because muscles of different size, shape, proportion of the oxidative and 
glycolytic fibres, or pattern of activation may be affected by different genetic 
mechanisms.  The soft tissues were removed from the tibia and bone length was 
measured to a precision of 0.01 mm with a digital caliper (Z22855, OWIM GmbH & Co). 
Apparent bone mineral content 
Mineral content of the tibia was measured with the Faxitron MX-20 scanner (Faxitron 
Bioptics LLC, AZ, USA) using methods adapted from (Bassett et al., 2012). Three types of 
materials; 0.8 mm of aluminium, 1.0 mm of polystyrene and 0.8 mm of steel, were 
scanned together with the bones for calibration of the image.  ImageJ (V1.48p, National 
Institutes of Health, USA) was used to quantify the apparent bone mineral content, 
appBMC, and the bone size. The appBMC was characterized by the mean, mode, median, 
minimum, maximum, standard deviation, skewness and kurtosis of the optical density of 
bone image. The bone area, perimeter, Feret’s diameter (longest distance between 2 
points on the perimeter), and width and height of the bounding rectangle characterized 
the bone size. 
 28 
Pre-processing of Phenotype Data 
Analysis of the phenotypic data was performed using the R statistical analysis software 
59. Outliers, defined as observations more than 3 standard deviations from the mean, 
were excluded. The effect of covariates such as sex and batch on quantitative phenotypes 
were assessed with analysis of variance (ANOVA) and those explaining more than 1% of 
the variance at P<0.05 were included in a multiple linear regression model from which 
residual measures were obtained. Batch, defined here as mice of the same age in each 
individual shipment, was treated as a random effect. All tests with covariates and models 
used to generate the residuals for genetic mapping are shown in Supplementary Table 1. 
We then quantile-normalised the residuals to minimize the effects of non-normality.  
 
Sequencing 
Genomic DNA was extracted from tissue samples of 2,028 mice that began the pipeline 
using Nucleon BACC resin (Hologic) following the manufacturer’s instructions. DNA was 
obtained from an additional 45 mice from the same population where no phenotypic 
measures were available producing a total of 2073 samples for analysis. Each individual 
DNA sample was then sonicated and barcoded with an in house unique 8-mer 
oligonucleotide 60. Groups of 95 barcoded DNA samples were pooled and pair end 100bp 
sequenced on 1 lane Hi-Seq generating read groups of ~30 Gb sequence per lane/pool. 
Alignment to mm10 reference and pre-processing of sequence data  
BWA version 0.5.6 61 was used to align the reads from each read group to the mouse 
mm10 reference genome. The BWA alignments were refined with Stampy v1.0.21 62 and 
converted into the bam format by samtools v0.1.18-dev63. Library PCR duplicates were 
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removed with samtools and sequence reads processed following the pipeline described 
11,13. All bam files were processed through the Indel Realignment and Base Quality Score 
Recalibration steps of the Genome Analysis Toolkit (GATK) 8 recommended Best 
Practices 64. All pre-processing used GATK v2.4-9-g532efad. The option –rf BadCigar was 
applied to filter out reads that a) have hard/soft clips in the middle of the CIGAR string, 
b) start or end in deletions, c) fully hard/soft clipped, d) have consecutive INDELs in 
them. The option –rf BadMate was applied to filter out reads whose mate maps to a 
different contig. Previously discovered INDELs from all mouse strains in the Mouse 
Genome Project (MGP) 11,65 were used as intervals for Indel Realignment in addition to 
those discovered in the 2073 mice, and SNPs from the Mus musculus domesticus strains 
in MGP were used as known sites masked for Base Quality Score Recalibration.  
Variant calling from low coverage sequencing data  
Variant calling was then performed using all 2073 bam files with GATK’s Unifed 
Genotyper with thresholds -stand_call_conf 30 and -stand_emit_conf 30, as well as 
options for building variant quality recalibration tables: -A QualByDepth -A 
HaplotypeScore -A BaseQualityRankSumTest -A ReadPosRankSumTest -A 
MappingQualityRankSumTest -A RMSMappingQuality -A DepthOfCoverage -A 
FisherStrand -A HardyWeinberg -A HomopolymerRun.  
Raw vcf files from variant calling step for all chromosomes except chromosome Y were 
pooled together for variant quality score recalibration (VQSR) using GATK’s 
VariantRecalibrator under SNP mode. Training, known and true sets for building the 
positive model are the SNPs which segregate among the classical laboratory strains of 
the Mouse Genomes Project 11 (2011 release REL-1211) on all chromosomes except 
chromosome Y. Transversion ratios (TsTv) and recalibration tables were generated at 14 
 30 
sensitivities (100.0, 99.9, 99.0, 97.0, 95.0, 90.0, 85.0, 80.0, 75.0, 70.0, 65.0, 60.0, 55.0, 
50.0) to training sets for runs of VQSR utilizing different sets of annotations. A final set of 
annotations for VQSR and sensitivities to known sites were chosen to maximize TsTv at 
both known and novel sites to reduce the rate of false positive calls. Sensitivity of 97% 
for known sites was selected for a total of 8,597,879 SNPs (6,430,809 known and 
2,177,070 novel, TsTv of 2.13 at known sites and 1.56 at novel sites). We then further 
removed sites that were fixed alternative allele variants (hence non-polymorphic in our 
study) or were multi-allelic, leaving 7,073,398 (5,701,865 known, 1,371,533 novel, TsTv 
of 2.13 at known sites and 1.56 at novel sites) biallelic SNPs. The annotations used for 
VQSR were HaplotypeScore, BaseQualityRankSumTest,  ReadPosRankSumTest, 
MappingQualityRankSumTest, RMSMappingQuality, DepthOfCoverage, FisherStrand, 
HardyWeinberg, HomopolymerRun.  
We used the 7M biallelic SNPs in the mice cohort for imputation, using the 
method described below. To ensure quality of the imputed of SNPs used for downstream 
genetic analysis, we first extracted those SNPs imputed with high certainty using 
IMPUTE2-style INFO scores. We observed from inspecting allele distributions that an 
INFO score greater than 0.4 indicated markers where the three genotype classes were 
clearly separable. Thus we included only sites that met this criterion. We also discarded 
sites where more than 10% of mice had maximum genotype probability smaller than 0.9, 
and on autosomal chromosomes we discarded sites where the P-value for violation of 
Hardy Weinberg equilibrium was smaller than 10-6.  This resulted in a final set of 5.76M 
SNPs that we used for genetic mapping. Lastly, we used the most current release of the 
Sanger mouse genomes database (2016, REL-1505, comprising 36 genomes, almost 
twice the original number) to refine the set of novel SNPs. The number of novel sites 
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among the 5.76M dropped from 799,133 (13.8%) to 152,671 (2.6%) (Supplemental 
Table S3). However, the TsTv ratios for the novel SNPs remained little changed, at 1.74 
and 1.73 respectively. 
  
Imputation 
We developed a novel imputation algorithm, STITCH, described in a separate publication 
(Davies et al). This employed a hidden Markov model (HMM) that extended the 
population genetic methods of Li and Stephens66, and more specifically the fastPHASE 
algorithm of Scheet and Stephens 67. We assume that the CFW population was founded 
with K unknown ancestral haplotypes and that the chromosomes of each sequenced 
CFW mice are mosaics of the founder haplotypes. After some experimentation with 
different values of K we found that K=4 was optimal (ie the population was modeled as 
being founded from two individuals). 
Simulating under the model (hidden ancestral states and sequencing reads) consists of: 
(i) choosing initial state probabilities (𝜋𝑘) from one of the k haplotypes (ii) choosing 
where to recombine between ancestral haplotypes assuming T=100 of generations since 
the population’s founding and a genetic distance between SNPs 𝑡 and 𝑡 + 1 (𝜎𝑡), (iii) 
choosing the ancestry within each segment with respect to the frequencies of each 
founder haplotype at that location (𝛼𝑡,𝑘), and (iv) sampling read locations, base qualities, 
underlying unobserved bases and observed sequenced bases, based on the relative 
probability that ancestral haplotype k emits a reference or ancestral base at SNP 𝑡 (𝜃𝑡,𝑘). 
Together, these represent the parameters of the model 𝜆 = (𝜋, 𝜎, 𝛼, 𝜃).  
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To generate the probabilistic genotype of an individual CFW outbred mouse, we first 
calculate the probability of observing a given sequencing read given membership in 
ancestral haplotype k, as follows. We first removed SNPs with low base quality (<17) and 
SNPs in reads with low mapping quality (<17). For an individual read 𝑅𝑟 indexed by r, let 
𝐽𝑟 be the number of SNPs in the read and 𝑃(𝑠𝑟,𝑗|𝑔𝑖 = 𝑖) = 𝜙𝑟,𝑗
𝑖  the base-quality scaled 
emission probability of sequencing read 𝑠𝑟,𝑗  given true underlying genotype i. Let SNP 𝑗 
in read 𝑅𝑟 correspond to SNP 𝑢𝑟,𝑗. We assume the probability of a recombination within 
a read is low, so we assign each read as having been emitted from a central SNP 𝑡 = 𝑐𝑟 . 
Therefore, the probability of read 𝑅𝑟 given it came from ancestral haplotype 𝑘 is 
𝑃(𝑅𝑟|𝑞𝑡 = 𝑘) =  ∏ (𝜃𝑢𝑟,𝑗,𝑘𝜙𝑟,𝑗
1 + (1 − 𝜃𝑢𝑟,𝑗,𝑘) 𝜙𝑟,𝑗
0 ) 
𝐽𝑟
𝑗=1
 
and the probability of observing all reads at SNP 𝑡 in a diploid sample given diploid 
hidden state at SNP t of 𝑞𝑡 = (𝑘1, 𝑘2) is  
𝑃(𝑂𝑡|𝑞𝑡 = (𝑘1, 𝑘2)) =  ∏ (
1
2
𝑃(𝑅𝑟|𝑞𝑡 = 𝑘1) + 
1
2
𝑃(𝑅𝑟|𝑞𝑡 = 𝑘2)) 
 
𝑟:𝑐𝑟=𝑡
 
The full chromosome diploid probability is then calculated using the initial, 
recombination and transition probabilities in the normal manner. 
We ran the method for 40 Expectation-Maximisation (EM) iterations, where in each 
iteration, during the expectation step, state probabilities are calculated for each mouse 
using the current parameters of the model, while in the maximization step, new initial, 
transition, recombination and emission parameters are estimated based on state 
probabilities. Upon completion, haplotype and genotype probabilities, as well as dosages, 
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are calculated. For example, the dosage of the number of Alt alleles is 1* P(G = (Ref,Alt) | 
O, λ) + 2* P(G=(Alt,Alt) | O, λ) for a given mouse and SNP site. 
Selection of tagging SNPs 
We then identified a subset of 359,559 (353,697 autosomal) tagging SNPs with MAF > 
0.1% and LD r2< 0.98. Genotypes at these sites were called based on maximum genotype 
probability from imputation; genotypes were only called based on maximum genotype 
probabilities of higher than 0.9, mice with maximum genotype probability of smaller 
than 0.9 at a particular site would have a missing genotype at the site. 
Sample selection based on estimation of Identity by Descent (IBD) between samples  
Pairwise Identity by Descent (IBD) was estimated by calculation of pairwise Identity by 
State (IBS) using PLINK (v1.07) at the tagging SNPs located on the autosomal 
chromosomes. Mice were excluded from further analysis if they had estimated PIHAT of 
higher than 0.5 with at least one other mice, or percentage IBS=1 of higher than 0.75 
with at least one other mice, or percentage of IBS=0 of smaller than 0.25 with at least one 
other mice. 135 mice were excluded by the above criteria. 
Sample Selection based on Principal Component Analysis (PCA)  
Linkage Disequilibrium Adjusted Kinship (LDAK, version 5.9) 68 was used to estimate 
local linkage disequilibrium (LD) by calculation of local pairwise correlations between 
SNPs and generating weightings of each SNP in the calculation of a genetic relatedness 
matrix (GRM) adjusted for local LD. The GRM was generated using hard-called genotypes 
at the tagging SNPs of MAF > 5% from all autosomes. Principal component analysis 
(PCA) was performed on the GRM to derive the top 20 principal components (PCs). PC2 
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separates out four mice from the rest; these four mice were excluded from further 
analysis. 
Estimation of whole-genome SNP-based heritability  
LDAK (version 5.9) was used to generate a new GRM using hard-called genoytpes of MAF 
> 5% at the same tagging SNPs in mice remaining in the analysis. Restricted maximum 
likelihood (REML) was used to estimate h2 of each of the 200 phenotypes measured.  
 
QTL mapping 
We mapped quantitative trait loci (QTLs) at the tagging SNPs using purpose-written 
software in R. For each phenotype 𝑘, we used the quantile-normalised residuals 𝒚𝒌 for 
QTL mapping and heritability analysis. Although we found little evidence of unequal 
degrees of relatedness between the CFW mice, as a precaution we used mixed models to 
control for cryptic relatedness and to avoid false positive QTL calls. We first used the 
imputed dosages of the tagging SNPs on the autosomal chromosomes to compute 
genome wide kinship matrices (K). Thus, if 𝑎𝑖𝑝 is the imputed reference allele dosage of 
SNP 𝑝 in individual 𝑖 then the genetic relationship 𝐾𝑖𝑗 between individuals 𝑖, 𝑗 is defined 
to be the Pearson correlation coefficient of the vectors 𝑎𝑖𝑝, 𝑎𝑗𝑝 across all autosomal 
tagging SNPs 𝑝 . The 𝑖, 𝑗 ‘th element of the population-wide genetic relationship matrix 𝐾 
is 𝐾𝑖𝑗. We also computed leave-one-out kinship matrices 𝐾𝑐 for each chromosome 𝑐, 
using all tagging SNPs not on chromosome 𝑐.  
We modified the standard mixed model formulation for mapping QTLs by computing 
separate mixed models for each chromosome, in order to ameliorate the reduction in 
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statistical significance of a locus caused by the same information being present in the 
kinship matrix.  To test association between the phenotype 𝑘 and tagging SNP 𝑝 resident 
on chromosome 𝑐, we estimated the phenotypic covariance matrix 𝑉𝑘𝑐 = 𝜎𝑔𝑘𝑐
2 𝐾𝑐 + 𝜎𝑒𝑘𝑐
2 𝐼 
where the genetic and environmental variance components 𝜎𝑔𝑘𝑐
2 , 𝜎𝑒𝑘𝑐
2  are estimated as 
above, and factorized it into its square root using the eigen-decomposition  
𝑉𝑘𝑐 = 𝐸𝑘𝑐
′ Λ𝑘𝑐𝐸𝑘𝑐 = (𝐸𝑘𝑐
′ Λ𝑘𝑐
1 2⁄ 𝐸𝑘𝑐)
2 = 𝐴𝑘𝑐
2  
where 𝐸𝑘𝑐 is the orthogonal matrix of eigenvectors and Λ𝑘𝑐 the diagonal matrix of 
eigenvalues of  𝑉𝑘𝑐. Then we fitted the transformed mixed model 
𝒛𝒌𝒄 = 𝐴𝑘𝑐
−1𝒚𝒌 =  𝜇 + 𝛼(𝐴𝑘𝑐
−1𝒂𝒑) + 𝒆  
where 𝜇, 𝛼 are parameters to be estimated, and the error vector 𝒆 is uncorrelated so the 
model can be fit efficiently by computing the correlation coefficient of 𝒛𝒌𝒄 , 𝐴𝑘𝑐
−1𝒂𝒑.  
Nominal statistical significance at a locus was measured as the logP (the negative log10 of 
the P-value of the ANOVA comparing the fit of the allele model to the null model). We 
defined a candidate QTL as any locus such that the logP was at a local maximum 
compared to the tests at neighbouring loci, and no other locus within 3Mb had a larger 
logP.  
We estimated separate genome-wide thresholds for each phenotype, aiming to control 
the per-phenotype false discovery rate (FDR). We made 𝑄 = 100 permutations of each 
transformed phenotype vector 𝒛𝒌𝒄, keeping the transformed allele dosages fixed, and 
refitted the model. This is efficient because most of the computational effort in fitting a 
mixed model is reusable when fitting the permuted phenotypes. We found candidate 
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QTLs in the permuted data in the same way and estimated the per-phenotype FDR of a 
QTL as  
𝐹𝐷𝑅𝑘(𝑥) =
𝑃𝑘(𝑥)
𝑄𝑁𝑘(𝑥)
  
where 𝑁𝑘(𝑥), 𝑃𝑘(𝑥) are the numbers of QTLs with logP ≥ 𝑥 observed for phenotype 𝑘 in 
the unpermuted and permuted data respectively, and 𝑄 = 100 is the number of 
permutations. 
Fine mapping 
Once a QTL had been mapped using the tagging SNPs and exceeded the FDR threshold, 
association was re-calculated with all imputed SNPs (from the 5.7M set) in a 20Mb 
window around the peak using the same mixed model.  
Confidence Interval Estimation 
Confidence intervals were estimated by simulation. First, at each QTL, a residual 
phenotype was constructed by removing the effect of the top SNP at the QTL from the 
phenotype vector used in the QTL mapping above. This ablated the QTL whilst 
maintaining genetic contributions from elsewhere in the genome. Next, 1000 SNPs were 
selected at random, subject to the constraint that they were within 2.5Mb of the top SNP 
and were polymorphic in the subset of individuals phenotyped for the trait (where the 
95% interval estimate was 2.0 Mb or greater, we repeated the analysis using SNPs up to 
10Mb from the top SNP). A causal variant was simulated at the SNP, with effect size 
matching that of the top SNP, taking account of the allele frequency, and its trait value 
added to the residual phenotype. A local scan of the region using the same mixed model 
but the simulated phenotype was performed and the location and logP of the top SNP 
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recorded. Across the 1000 simulations, we estimated the distribution of the drop ∆ in 
logP between the simulated top SNP and the simulated causal SNP (this was zero when 
the top and causal SNPs coincided). We used the fraction of simulations 𝑓(∆) within ∆ to 
determine confidence intervals for the original phenotype data. Thus we identified the 
range of SNPs within 2.5Mb of the top SNP and with a logP drop less than ∆ to define the 
100𝑓(∆)% confidence interval for the QTL. We did this using both the tagging SNPs and 
the fine-mapping SNPs.  
Power Calculation 
Since we applied an FDR approach to call QTLs we did not require a logP threshold that 
would be required in order to determine power. However, in order to estimate power 
and the effects of sample size and effect size, we determined approximate genome-wide 
thresholds based on permutations of the mixed-model transformed phenotypes 𝑧 =
𝐴−1𝑦 keeping the genotypes fixed in order to preserve LD structure. For each of the 200 
phenotypes, we performed 100 permutations and computed the genome-wide maximum 
logP across the 359,559 tagging SNPs in order to define genome-wide thresholds 𝑇(𝑝) at 
𝑝 = 0.5, 0.1, 0.5 levels of significance (e.g. the threshold 𝑇(𝑝) is such that in a fraction 𝑝 
of simulations the genomewide maximum logP exceeds 𝑇(𝑝). Thresholds vary slightly 
between phenotypes, so we used the thresholds obtained by pooling all 20,000 
simulations to estimate power for sample sizes 𝑁 =  1000, 1732, 2000, 4000  and 
apparent effect sizes 𝑣 =  0.01, 0.016, 0.02. (𝑁 = 1732 and 𝑣 = 0.016 are the median 
sample size and effect size in the current study). Power 𝜋(𝑁, 𝑣, 𝑇) to detect a QTL with 
effect size 𝑣 and sample size 𝑁 at genome-wide logP threshold 𝑇, was computed as 
 𝜋(𝑁, 𝑣, 𝑇) = Pr(𝑋 > 𝑤(𝑇)| 𝑋 ~ 𝜒1,𝑁𝑣
2 )  where 𝜒1,𝑁𝑣
2  is the noncentral chi-square 
distribution on 1df with noncentrality parameter 𝑁𝑣, and  𝑤(𝑇) is the quantile of a 
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standard chi-squared distribution corresponding to logP 𝑇, ie  Pr(𝑋 > 𝑤(𝑇)| 𝑋 ~ 𝜒1,0
2 ) =
 10−𝑇. 
Data availability 
Results from this project and the data used for analysis are maintained in an open access 
database, available at http://outbredmice.org. Sequencing reads are obtainable from the 
European Nucleotide Archive: http://www.ebi.ac.uk/ena/data/view/ERP001040. 
Software availability 
Custom R code for QTL mapping, written specifically for this project, is available from 
Richard Mott (r.mott@ucl.ac.uk). STITCH is available from Robert Davies 
(robertwilliamdavies@gmail.com) 
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Tables 
Table 1. QTLs mapping to a single gene 
Phenotype Chr. 
Position 
(Mb) -logP Gene 
Refere
nces 
Knock-out mouse recapitulates the phenotype 
Weight of soleus muscle (g) 6 17.5 16.2 Met  21-23 
Total distance travelled in Elevated Plus 
Maze (cm) 6 110.2 5.6 Grm7  
25 
CD45+/CD3-/CD19+ cells (%) 9 32.6 5.8 Fli1 24 
Association supported by literature 
CD45+/CD3-/DX5+ cells (%) 1 168.2 4.7 Pbx1 30 
Wound healing 2 134.2 5.5 Bmp2 26 
Number of long (>1min) sleep episodes 5 51.8 6.8 Ppargc1a 27 
Ratio of CD3+/CD4+ to CD3+/CD8+ cells 8 82.4 8.7 Il15 31 
Bone mineral content 11 108.2 4.6 Prkca 28,29 
CD3+/CD8+ cells (%) 12 25.5 5.4 Id2 32 
No previous evidence 
Length of tibia (mm) 5 51.7 4.5 Ppargc1a  
Startle pulse reactivity 6 17.5 6.7 Met  
Calcium (mmol/l) 6 17.5 8.3 Met  
Total Cholesterol (mmol/l) 6 17.5 6.1 Met  
Total Protein (g/l) 6 17.5 27.7 Met  
CD45+/CD3-/CD19+ cells (%) 7 72.2 6.2 Mctp2  
Number of long (>1min) sleep episodes  9 73.8 5.5 Unc13c  
Startle pulse reactivity 10 68.0 8.0 Rtkn2  
Weight of tibialis anterior muscle (g) 11 17.6 6.3 Etaa1  
Length of tibia (mm) 12 83.6 7.1 Zfyve1  
Basal activity 13 7.3 10.6 Adarb2  
Respiratory rate during Hypoxic 
Ventilatory Decline 13 118.0 5.9 Hcn1 
 
Total distance travelled in Elevated Plus 
Maze (cm) 14 82.1 6.2 Pcdh17 
 
Measure of the size of tibia 15 26.6 5.3 Fbxl7  
Percentage of Eosinophils (%) 17 70.4 5.2 Dlgap1  
Percentage of Eosinophils (%) X 155.6 6.0 Ptchd1  
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Figure Legends 
 
Figure 1 
Sequence diversity of the CFW population. (a) Distribution of heterozygosity in 100kbp 
windows genome-wide. (b) Histogram of genome-wide heterozygosity. (c) Example of 
novel and total SNP density for a region of chromosome 19. Results are representative of 
those seen genome-wide. (d) Minor allele frequency (MAF) density for population of 
wild Indian (n=10, 44.9 M whole genome sequencing SNPs), CFW mice (n=2,073, 5.7M 
imputed SNPs) and HS mice (n=1,904, 11K SNPs from a genotyping array). Known CFW 
variation refers to those variants also segregating among 14 sequenced classical inbred 
strains. (e) The extent of linkage disequilibrium in CFW and HS mice. Values are mean r2 
between all pairs of SNPs binned by distance to the kbp.  
 
Figure 2  
Properties of QTLs. Frequency distribution of (a) the size and (b) the number of genes 
present in the 95% confidence intervals (CI) in 255 QTLs, (c) The sum of variance 
explained by the QTLs plotted against heritability in 92 measures where heritability 
could be estimated and at least one QTL was detected. Colour of dots indicates the type 
of measure: behaviour, physiological (body weight, respiratory, electrocardiography) or 
tissue (any measure obtained after dissection) 
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Figure 3 
Summary Manhattan plot. Genome-wide representation of all unique QTLs (n=156, 
FDR<5%) identified in this study. Light and dark grey dots show association from the 92 
measures where at least one QTL was detected at the tagging SNPs positions 
(n=359,559). Most significant SNPs at each QTL are marked with a colour dot, depending 
on the type of measure. Y-axis shows –log10(P) of the imputed allele dosages with tested 
measures and is truncated at –log10(P)=32. The position of the 2 strongest QTLs with –
log10(P) values of 133 (chr4) and 76 (chr17) is marked by triangles. 
 
Figure 4  
Single-gene resolution mapping at 4 loci using the entire set of SNPs (7.1 M). (a) Weight 
of soleus muscle on chromosome 6 (n=1832), (b) Measure of the number of long sleep 
episodes on chromosome 9 (n=1577), (c) Ratio of CD3+/CD4+ to CD3+/CD8+ cells on 
chromosome 8 (n=1324) and (d) Intensity of reaction to startle on chromosome 10 
(n=1740). The plots were drawn using LocusZoom 69. Strongest associated SNP is 
marked with a purple diamond, the other SNPs that passed post-imputation quality 
control (IMPUTE2-style INFO scores > 0.4 and HWE r2>1e-6,) are coloured following LD 
r2 with strongest SNP. The grey dots represent SNPs that failed post-imputation QC and 
therefore were not used for the analysis. 
